In a filing submitted March 18, plaintiffs argue that the drug makers overstated the benefits of GLP-1 drugs while minimizing the risk of serious gastrointestinal injuries, including gastroparesis, ileus, and intestinal obstruction
As an adjunct to diet and exercise to lower blood sugar in adults with T2DM To reduce risk of hospitalization for heart failure in patients with heart disease or cardiovascular risk factors To slow progression of chronic kidney disease and reduce kidneyrelated and cardiovascular death risk in CKD patients Not approved for type 1 diabetes or treatment of diabetic ketoacidosis How does Farxiga work
If you notice any unusual symptoms while using this medicine, consult your doctor
This is reported context, not a recommendation
We anticipate that continued investigation will clarify how these peptides fit into broader peptide-based therapeutic strategies
19) to express her displeasure with media coverage, and to open up about experiencing anxiety in the spotlight
